Vironova AB Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Vironova AB's estimated annual revenue is currently $8.2M per year.(i)
  • Vironova AB's estimated revenue per employee is $126,000

Employee Data

  • Vironova AB has 65 Employees.(i)
  • Vironova AB grew their employee count by -44% last year.

Vironova AB's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Business Unit, EM ServicesReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Quality DirectorReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Lab Manager Research and InnovationReveal Email/Phone
7
Team ManagerReveal Email/Phone
8
Senior QA ManagerReveal Email/Phone
9
Project Manager - Vironova Analyzer SoftwareReveal Email/Phone
10
Software developerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.1M1-50%$5MN/A
#2
$30.6M1990%N/AN/A
#3
$7.2M570%N/AN/A
#4
$3.7M33-6%N/AN/A
#5
$0.3M4-56%N/AN/A
#6
$3.7M33-20%N/AN/A
#7
$5.4M487%N/AN/A
#8
$0.3M4-20%N/AN/A
#9
$2.5M264%N/AN/A
#10
$12.9M921%N/AN/A
Add Company

What Is Vironova AB?

Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better informed decisions to secure robust bioprocessing and final product quality. The Vironova offering comprises: Cost effective, fast electron microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis. Viral clearance testing performed in GLP and BSLIII certified laboratories. MiniTEMâ„¢, a bench-top transmission electron microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics. Founded in 2005 as a result of interdisciplinary research at the Karolinska Institute in Stockholm Sweden, Vironova has quickly established a following of global customers working in highly-regulated and quality-demanding industries such as vaccine development, the pharmaceutical industry and material science.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$8.2M

Revenue (est)

-44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vironova AB News

2022-04-17 - Virale Clearance Marktnachfrage 2022 ...

... deckt zusammen spezifische Anwendungsbereiche des Marktes in jeder region ab. ... Kedrion, Vironova Biosafety, Texcell, Clean Cells.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.4M65-4%N/A
#2
$7.6M65-3%N/A
#3
$9.5M6548%N/A
#4
$11.9M65-6%N/A
#5
$12.9M6533%N/A